Black Rock Inc. Pasithea Therapeutics Corp. Transaction History

Black Rock Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$16.52 - $27.0 $164,572 - $268,974	-9,962 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$19.4 - $35.8 $28,323 - $52,267	1,460 Added 17.17%	9,962 $13,000
Q4 2021 Feb 10, 2022	BUY	$28.8 - $112.0 $244,857 - $952,224	8,502 New	8,502 $15,000

Ticker KTTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,398,700
Market Cap $157M
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.